Table 3.

Endovascular therapy in acute CVT

TrialStudy designNo of patientsInterventionResultsLimitations
Coutinho et al36 
(TO-ACT trial) 
Randomized, controlled 67 Endovascular treatment in patients
Inclusion criteria: ≥1 Risk factor for clinical deterioration (coma, mental status changes, CVT in deep venous system, intracerebral hemorrhage) 
Stopped prematurely for futility Small sample size 
Dentali et al37  Systematic review of 15 studies 156 Mechanical thrombectomy/thrombolysis Death rate 9%
Major bleeding 10% with local thrombolysis
8% intracranial hemorrhage
58% fatal 
 
Siddiqui et al40  Systematic review of 42 studies 185 Mechanical thrombectomy/thrombolysis (71%)
60% pretreatment intracranial hemorrhage
47% stupor, coma 
84% good outcome
12% mortality
10% new/worsened intracerebral hemorrhage
95% recanalization rate 
Concern for bias as the studies were not blinded 
TrialStudy designNo of patientsInterventionResultsLimitations
Coutinho et al36 
(TO-ACT trial) 
Randomized, controlled 67 Endovascular treatment in patients
Inclusion criteria: ≥1 Risk factor for clinical deterioration (coma, mental status changes, CVT in deep venous system, intracerebral hemorrhage) 
Stopped prematurely for futility Small sample size 
Dentali et al37  Systematic review of 15 studies 156 Mechanical thrombectomy/thrombolysis Death rate 9%
Major bleeding 10% with local thrombolysis
8% intracranial hemorrhage
58% fatal 
 
Siddiqui et al40  Systematic review of 42 studies 185 Mechanical thrombectomy/thrombolysis (71%)
60% pretreatment intracranial hemorrhage
47% stupor, coma 
84% good outcome
12% mortality
10% new/worsened intracerebral hemorrhage
95% recanalization rate 
Concern for bias as the studies were not blinded 

or Create an Account

Close Modal
Close Modal